P-49 COVID 19-PANDEMIC AND OUTCOMES IN DECOMPENSATE CIRRHOSIS-10 MONTHS REVIEW

Background and Aims: Liver abnormalities are frequent in COVID-19 disease, AST and ALT abnormalities are present in about 60% of serious disease patients. However, liver insufficiency and liver mortality were not important concerns. Decompensate cirrhotic patients are a group of high risk for morbid...

Full description

Bibliographic Details
Main Authors: Priscila Pollo-Flores, Gabriel Alverca Meyas, Vanessa Rodrigues, Janaisa Moraes de Souza, Pamela Moura Rodrigues Cardoso, Iasmin Torres Leitão, Stephanie Cathren Fenizola dos Santos da Silva, Lívia Melo Villar
Format: Article
Language:English
Published: Elsevier 2021-09-01
Series:Annals of Hepatology
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268121001125